Nestlé has announced plans to launch frozen foods that target weight-loss drug users. In the last year, GLP-1 weight loss and diabetes drugs like Ozempic and Wegovy have skyrocketed in use as ...
Nestle is getting into the weight loss business. The world’s largest food and beverage company said it plans to launch a frozen food brand that will cater to consumers who use GLP-1 drugs such ...
Nestlé is launching a frozen food brand specifically aimed at people taking GLP-1 diabetes and weight loss drugs like Ozempic and Wegovy, the company announced Tuesday, part of the food giant’s ...
Nestle plans to launch a frozen-food brand Vital Pursuit aimed at consumers who are taking Ozempic and Wegovy. GLP-1 drugs have taken off for weight loss and diabetes treatment, sparking investor ...
Major corporations are tapping into the lucrative weight loss drug market, which is anticipated to grow from $6 billion to $100 billion by 2030, per Goldman Sachs. Last month, Costco announced ...
As the global focus on health and weight management intensifies, Nestle has announced the launch of Vital Pursuit, a brand specifically catering to individuals using GLP-1 weight loss medications ...
TheStreet’s Conway Gittens brings the latest business headlines from the floor of the New York Stock Exchange as markets close for trading Tuesday, May 21. CONWAY GITTENS: I’m Conway Gittens ...